newsfilter
← Latest News
GlobeNewswire·

BioXcel Therapeutics Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirement

NEW HAVEN, Conn., May 27, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today